Olema Pharmaceuticals, Inc.·4

Feb 2, 5:34 PM ET

Moriarty John B 4

4 · Olema Pharmaceuticals, Inc. · Filed Feb 2, 2023

Insider Transaction Report

Form 4
Period: 2023-02-01
Moriarty John B
EVP, Ch. Legal Officer & Sec.
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-01+150,000150,000 total
    Exercise: $4.87Exp: 2033-01-31Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION